Researcher Spotlight: Our Researcher Showcase and Symposium 2018

Researcher Spotlight: Our Researcher Showcase and Symposium 2018

Cure Cancer Australia researchers, alumni and supporters came together at our annual Researcher Symposium and Showcase to celebrate the achievements of our Class of 2018 Researchers.

Late last month, our Class of 2018 researchers gathered at the Melanoma Institute in Crows Nest for the annual Cure Cancer Australia Researcher Symposium.

The Researcher Symposium is an important platform for our early-career researchers to present their innovative ideas and approaches to improving the prevention, detection and treatment of all cancers. It’s also an excellent opportunity for them to engage with their peers and mentors, assisting in creating collaboration within their research industry.

This year, we were privileged to have five keynote and guest speakers, chosen for their exceptional contribution to Cure Cancer Australia and the scientific and medical research community. We would like to extend sincere thanks to our two keynote speakers; Prof Glenn Begley, Chief Executive at BioCurate; Prof David Vaux, Deputy Director of the Walter and Eliza Hall Institute (WEHI); and invited speaker Associate Professor Nikola Bowden, DNA Repair Group Leader and a Cancer Institute NSW Career Development Fellow in the Cancer Research Program of Hunter Medical Research Institute (HMRI). Also to our guest speakers who took the time out of their busy schedules to be with us; Cure Cancer Australia Community Fundraiser and Ambassador Lisa Greissl, and Cure Cancer Australia Community Fundraiser Kate Massey.

Later in the evening, current researchers, alumni and Cure Cancer Australia supporters gathered at the Garvan Institute of Medical Research for our evening event, the Cure Cancer Australia Researcher Showcase.

Guests were greeted with drinks and canapés before moving through the auditorium to be welcomed by Cure Cancer Australia Board Chairman, Philip Corne. Our MC for the evening, Ian Rumsby, then went on to introduce Prof Glenn Begley, whose inspirational key note address highlighted the importance of funding early career researchers to ensure we continue to support breakthroughs in cancer treatments. 

Cancer survivor and Cure Cancer Australia Board Director John Ball then led our esteemed panel of Cure Cancer Australia alumni in a Q & A session, which once again highlighted the importance of funding innovative research from our brightest young minds. Thanks to our panel members, Associate Professor Viive Howell, Dr Susi Woods, Dr Andreas Behren, Associate Professor Steven Lane and Dr Fatima Valdes Mora, who spoke about their research projects and how crucial our grant funding has been in advancing their careers.

Congratulations to Associate Professor Jyotsna Batra from Translational Research Institute & Queensland University of Technology who was awarded 2018 Researcher of the Year, as well as Associate Professor Gillian Gould and Dr Fernando Guimaraes who were runners up. All three were awarded travel grants to be used for an approved purpose.

Finally, a special thank you to the Melanoma Institute Australia for their generous support in hosting this year’s Symposium; the Garvan Institute of Medical Research for hosting our Researcher Showcase; and the Research Consultative Committee for their support of this event.

This year’s Symposium and Showcase were held during Cancer Research Awareness Week, a national awareness week designed to highlight the importance of supporting Australia’s brightest emerging cancer researchers. We are very proud to be associated with such an inspiring group of emerging researchers. Cure Cancer Australia funds research projects with the best possible chance of reducing the burden of cancer, and the emerging research stars of tomorrow, all whom are fearless in their development and exploration of ground-breaking ideas.


One more thing...

With your help, we can continue to fund early-career researchers, like the class of 2018 who are working across ALL cancers and ALL areas of cancer research.

... ...